Aastrom Biosciences (ASTM) 1.84 -0.01

Aastrom Biosciences, Inc.
(ASTM) 1.84 -0.01

Last Trade:	1.83	Day Range:	1.83 - 1.90
Trade Time:	08:02PM	52wk Range:	1.75 - 3.14
Prev. Close:	1.84	Market Cap:	70.7M
Open:	1.83	Div Yield:	0
Volume:	155793	PE:
EPS:	-0.65

The Latest On ASTM

Kraton Polymers Announces Exceptional Performance Results in Corrosion-resistant Coatings 1/9/12 9:04am

FDA Warns About Unproven Stem Cell Claims 1/8/12 7:11pm

Does Aastrom Biosciences Have a Leg to Stand On? 11/15/11 3:11pm

Even as Geron Shares Drop Other Players Converge on Stem Cells Space 11/15/11 12:37pm

Aastrom Reports Positive 12-Month Results from the RESTORE-CLI Phase 2 Clinical Trial for Ixmyelocel-T 11/14/11 11:15am

Aastrom Biosciences Phase 2 Data to be Released at 11:15 a.m. ET 11/14/11 8:45am

Oppenheimer Initiates Aastrom Biosciences at Perform 10/21/11 7:06am

Aastrom Granted European Composition-of-Matter Patent for Ixmyelocel-T 10/3/11 8:00am

McNicoll, Lewis & Vlak Maintains Aastrom Biosciences Buy, $7.50 PT 9/19/11 5:02pm

Aastrom Announces Positive 12-Month Safety and Efficacy Data From IMPACT-DCM Phase 2 Clinical Trial for Ixmyelocel-T in Treatment of Dilated Cardiomyopathy 9/19/11 8:01am

UPDATE: MLV Raises PT on Aastrom Biosciences to $7.50 8/16/11 8:19am

Global Hunter Initiates Aastrom Biosciences At Speculative Buy, $6 PT 8/12/11 7:29am

Kraton Polymers Announces Exceptional Performance Results in Corrosion-resistant Coatings 1/9/12

FDA Warns About Unproven Stem Cell Claims 1/8/12

Does Aastrom Biosciences Have a Leg to Stand On? 11/15/11

Even as Geron Shares Drop Other Players Converge on Stem Cells Space 11/15/11

Aastrom Reports Positive 12-Month Results from the RESTORE-CLI Phase 2 Clinical Trial for Ixmyelocel-T 11/14/11

Aastrom Biosciences Phase 2 Data to be Released at 11:15 a.m. ET 11/14/11

Oppenheimer Initiates Aastrom Biosciences at Perform 10/21/11

Aastrom Granted European Composition-of-Matter Patent for Ixmyelocel-T 10/3/11

McNicoll, Lewis & Vlak Maintains Aastrom Biosciences Buy, $7.50 PT 9/19/11

Aastrom Announces Positive 12-Month Safety and Efficacy Data From IMPACT-DCM Phase 2 Clinical Trial for Ixmyelocel-T in Treatment of Dilated Cardiomyopathy 9/19/11

UPDATE: MLV Raises PT on Aastrom Biosciences to $7.50 8/16/11

Global Hunter Initiates Aastrom Biosciences At Speculative Buy, $6 PT 8/12/11

15 Low Priced Stocks to watch on the move (CRDC),(FXEN),(RDNT),MOSY) more below 1/10/11

Low Priced Movers (ASTM),(OMEX), (EDAP), (RUTH), (GU),(BRKS) 1/10/11

Stocks That Created New 52-Week Lows (ASTM, CRIC, NLCI, PLUG, SBLKW) 1/21/10

STEM, GERN and ASTM shares seeing unusual movement following the NIH Announcement 12/2/09

Oppenheimer Initiates Aastrom Biosciences at Perform 10/21/11

McNicoll, Lewis & Vlak Maintains Aastrom Biosciences Buy, $7.50 PT 9/19/11

UPDATE: MLV Raises PT on Aastrom Biosciences to $7.50 8/16/11

Global Hunter Initiates Aastrom Biosciences At Speculative Buy, $6 PT 8/12/11

Stifel Nicolaus Initiates ASTM With A Buy Rating, $4.50 PT 3/28/11

Trade ASTM
NOW!

Partner Headlines

Aastrom CEO: Financing Close to Completion 1/18/12

Weekly CFO Sells Highlight: P, MTOR, PSSI, ASTM 1/8/12

Aastrom Biosciences Inc. (ASTM) CFO Scott Durbin sells 40,000 Shares 1/6/12

Aastrom Cell Therapy Reverses Effects of Blocked Leg Arteries 11/14/11

Biotech Calendar: Key Dates for November 11/1/11

Cytomedix Fundamentals Improving - Analyst Blog 9/1/11

Press Releases

YKK AP Launches Impact-Resistant Patio Door for Coastal Area Homes 1/25/12 Business Wire Story

Electro Scan Inc. Announces New Products to Overhaul Sewer Pipeline Evaluation Market 1/23/12 PRWeb Story

Electro Scan Inc. Announces New Products to Overhaul Sewer Pipeline Evaluation Market 1/23/12 Business Wire Story

NSF International Selected to Administer Biodegradable Products Institute's Certified Compostable Program for Plastic Products 1/11/12 PRWeb Story

Kraton Polymers Announces Exceptional Performance Results in Corrosion-resistant Coatings 1/9/12 Newswire Story

Taking Care With Deicing Salts Can Protect Pavers, According to New Whitepaper 12/12/11 PRWeb Story

Bruker and Symphony Environmental Sign Agreement on X-Ray Fluorescence (XRF) Technology Enabling Identification of the Components of Plastic 11/23/11 Business Wire Story

Aastrom Biosciences to Present at Piper Jaffray 23rd Annual Health Care Conference in New York City 11/22/11 GlobeNewswire Story

Aastrom Reports Positive 12-Month Results from the RESTORE-CLI Phase 2 Clinical Trial for Ixmyelocel-T in Patients with Critical Limb Ischemia 11/14/11 GlobeNewswire Story

Symphony at APEC AND PBEC Conferences in Hawaii 11/14/11 PRWeb Story

Aastrom Biosciences to Hold Research and Development Day Review for Investors on November 17, 2011 11/11/11 GlobeNewswire Story

Aastrom Biosciences Reports Third Quarter 2011 Financial Results 11/8/11 GlobeNewswire Story

Get the latest ASTM stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Aastrom Biosciences, Inc. stock price.

Aastrom Biosciences, Inc. by YCharts